Skip Navigation Links.

Aurobindo Pharma Ltd


BSE: 524804 | NSE: AUROPHARMA | ISIN: INE406A01037 
Market Cap: [Rs.Cr.] 3,400 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

MF Investments

Scheme NameInv DateAmount
Invested
(Cr.)		% Net
Assets		Total NAV
[Cr.]
HSBC Progressive Themes Fund (G) 30-Apr-12 4.81 2.7 179.28
DSP BR Tax Saver Fund (G) 30-Apr-12 3.24 0.4 735.61
HSBC Monthly Income Plan - Savings (G) 30-Apr-12 2.14 0.9 247.51
HSBC Monthly Income Plan (G) 30-Apr-12 0.37 0.3 133.73
HDFC Balanced Fund (G) 30-Apr-12 0.00 1.1 0.00
UTI-Pharma & Healthcare Fund (D) 30-Apr-12 0.00 1.4 0.00
SBI Tax Advantage Fund - Series I (G) 30-Apr-12 0.00 4.8 0.00
Reliance Pharma Fund (Bonus) 30-Apr-12 0.00 3.3 0.00
UTI-India LifeStyle Fund (G) 30-Apr-12 0.00 0.1 0.00
HDFC Top 200 Fund (G) 30-Apr-12 0.00 0.9 0.00
ICICI Pru Discovery Fund (G) 30-Apr-12 0.00 1.5 0.00
SBI Tax Advantage Fund - Series II (G) 30-Apr-12 0.00 7.9 0.00
Reliance Arbitrage Advantage Fund (G) 30-Apr-12 0.00 3.4 0.00
SBI Magnum SFU - Pharma Fund (D) 30-Apr-12 0.00 3.0 0.00
HDFC Prudence Fund - (G) 30-Apr-12 0.00 1.0 0.00
ICICI Pru MidCap Fund (G) 30-Apr-12 0.00 1.1 0.00
Morgan Stanley A.C.E Fund (G) 30-Apr-12 0.00 1.6 0.00
HDFC Equity Fund - (G) 30-Apr-12 0.00 1.2 0.00
UTI-MIS Advantage Plan (G) 30-Apr-12 0.00 0.4 0.00
HDFC Arbitrage Fund (G) 30-Apr-12 0.00 0.8 0.00
IDFC Premier Equity Fund - Plan A (G) 30-Apr-12 0.00 1.2 0.00
HDFC Mid-Cap Opportunities Fund (G) 30-Apr-12 0.00 1.5 0.00
IDFC Arbitrage - Plan A (G) 30-Apr-12 0.00 0.5 0.00

Peer Comparison

Company Market Cap
(Rs. in Cr.) 		P/E (TTM)
(x) 		P/BV (TTM)
(x) 		EV/EBIDTA
(x) 		ROE
(%) 		ROCE
(%) 		D/E
(x)
Sun Pharma.Inds. 59,137.94 36.99 8.85 29.33 22.3 23.3 0.01
Dr Reddy's Labs 28,699.73 31.46 4.27 22.23 15.0 15.2 0.17
Cipla 24,821.65 22.08 3.31 18.79 15.4 17.9 0.04
Ranbaxy Labs. 22,385.02 17.92 11.63 0.00 0.0 0.0 1.22
Cadila Health. 15,250.06 23.20 5.98 21.79 32.9 27.5 0.31
Glenmark Pharma. 9,530.53 35.94 4.36 24.56 11.3 11.9 0.51
Wockhardt 8,445.48 29.36 70.28 39.85 0.0 0.0 3.18
Piramal Health 7,212.59 55.15 0.65 0.33 4.2 6.1 0.07
Torrent Pharma. 5,411.87 14.92 4.15 11.43 29.5 25.9 0.55
Biocon 4,324.00 16.92 2.06 11.21 26.2 26.8 0.10
Ipca Labs. 4,199.83 15.43 3.99 10.26 26.5 25.1 0.51
Strides Arcolab 3,959.34 61.18 2.92 16.20 5.1 5.7 0.97
Aurobindo Pharma 3,400.05 10.56 1.32 8.01 26.5 19.7 0.95
Matrix Labs. 3,273.19 8.13 2.00 0.00 28.9 27.4 0.52
Fres.Kabi Onco. 2,214.80 84.85 4.09 16.45 9.5 10.8 0.58

Futures & Options Quote

 
Expiry Date
116.85 1.20  (1.0%)
Instrument: FUTSTK
Expiry Date: 31 May 2012
Open Price: 114.75
Average Price: 115.53
No. of Contracts Traded: 1,042,000
Open Interest: 2,170,000
Underlying: AUROPHARMA
Market Lot: 2000
Previous Close: 116.85
Day’s High | Low: 118.20 | 112.05
Turnover (Cr.): 12.04
Open Int. Change: -102,000.00 ( [4.5]% )
View detailed F& O quotes >>

Key Information

Key Executives:

P V Ramprasad Reddy , Chairman 

K Nithyananda Reddy , Managing Director 

M Sivakumaran , Whole-time Director 

M Madan Mohan Reddy , Whole-time Director 

Company Head Office / Quarters:
Plot No 2 Maitri Vihar,
Behind Maithri Vanam Ameerpet,
Hyderabad,
Andhra Pradesh-500038
Phone : 91-040-66725000
Fax : 91-040-23741080/23746833
E-mail : info@aurobindo.com
Web : http://www.aurobindo.com
Registrars:
Karvy Computershare Pvt Ltd
Plot No 17-24
Vittal Rao Nagar
Madhapur
Hyderabad-500081

Calendar

May-2012
M T W T F S S
21 22 23 24 25 26 27
IPO
listNo IPO today
Economic Events
list Corporate Service Price (YoY)
list Hometrack Housing Survey (MoM)
Results
list No result today